Danaher Corp (NYSE:DHR)

CAPS Rating: 5 out of 5

The Company designs, manufactures and markets professional, medical, industrial and consumer products, its business consists of four segments: Professional Instrumentation, Medical Technologies, Industrial Technologies and Tools & Components.


Player Avatar PDueDiligence (40.89) Submitted: 4/12/2010 9:53:56 AM : Outperform Start Price: $39.82 DHR Score: +35.47

The stock is currently undervalued on a future P/E perspective. DHR produces very consistent earnings and usually trades at a conservative 21x PE ratio. It is trading at 23.21x current earnings ratio on the expectation of a large Q1 2010 number.

Fair present value is:
2010 fair value of DHR:
P/E valuation: (21*4.13) = $86.73
2011 fair value of DHR:
P/E valuation: (21*4.72) = $99.12

Please see the Practice Due Diligence blog article for DHR for further research:


DHR is my highest conviction pick for the long term. DHR presents an opportunity to outperform the broad market at a very low risk for the foreseeable future.

RL- Long Position in DHR is 18.6% of Total Portfolio

Member Avatar PDueDiligence (40.89) Submitted: 5/13/2010 8:54:19 AM
Recs: 0

I added 30% to my position @ $82.50; I didn't catch the bottom of the dip but that is ok. I have a sell order in at $91.50 22x 2010 earnings.

Featured Broker Partners